市場調查報告書

照護現場 (POC) 分子診斷的全球市場 - 至2027年的預測

Point of Care Molecular Diagnostics Market by Product and Solution (Assay, Analyzer, Software, Services), Technology (RT-qPCR, INAAT), Application (Respiratory Diseases, Hospital Acquired Infections, STD), and End User - Global Forecast to 2027

出版商 Meticulous Market Research Pvt. Ltd. 商品編碼 928253
出版日期 內容資訊 英文 158 Pages
訂單完成後即時交付
價格
照護現場 (POC) 分子診斷的全球市場 - 至2027年的預測 Point of Care Molecular Diagnostics Market by Product and Solution (Assay, Analyzer, Software, Services), Technology (RT-qPCR, INAAT), Application (Respiratory Diseases, Hospital Acquired Infections, STD), and End User - Global Forecast to 2027
出版日期: 2020年03月11日內容資訊: 英文 158 Pages
簡介

照護現場 (POC) 分子診斷市場,至2027年預計將達到23億9000萬美元,2019年∼2027年間預測將以年複合成長率13.2%的速度成長。

本報告提供全球照護現場 (POC) 分子診斷市場相關調查分析,市場概要,市場規模與預測,各市場區隔的市場分析,各地區的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 簡介

第2章 調查方法

第3章 摘要整理

第4章 市場考察

  • 簡介
  • 促進因素
  • 阻礙因素
  • 機會
  • 課題

第5章 照護現場 (POC) 分子診斷市場:各產品

  • 簡介
  • 套件、化驗
  • 分析設備
  • 軟體、服務

第6章 照護現場 (POC) 分子診斷市場:各技術

  • 簡介
  • 即時定量的聚合酵素鏈鎖反應 (Rt-QPCR)
  • 恆溫核酸增幅技術 (INAAT)
  • 其他

第7章 照護現場 (POC) 分子診斷市場:各適應症

  • 簡介
  • 呼吸疾病
  • 性感染疾病 (STD)
  • 院內感染 (HAI)
  • 腫瘤學
  • 新生兒、產前檢查
  • 其他

第8章 照護現場 (POC) 分子診斷市場:各終端用戶

  • 簡介
  • 診所、臨床檢驗室
  • 醫院的門診病人診療部門 (OPD) 、加護病房 (ICU)
  • 研究、學術機構
  • 其他

第9章 照護現場 (POC) 分子診斷市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第10章 競爭情形

  • 簡介
  • 主要的成長策略
  • 競爭基準
  • 市場佔有率分析

第11章 企業簡介

  • Alere Inc.
  • Quidel Corporation
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Biomerieux SA
  • Meridian Bioscience, Inc.
  • Mesa Biotech Inc.
  • GeneSTAT Molecular Diagnostics, LLC
  • Biocartis Group NV

第12章 附錄

目錄

Point of Care Molecular Diagnostics Market by Product & Solution (Assay, Analyzer, Software, Services), Technology (RT-qPCR, INAAT), Application (Respiratory Diseases, Hospital Acquired Infections, STD), End User (Clinics, Research) - Forecast to 2027

The point of care (POC) molecular diagnostics market is expected to grow at a CAGR of 13.2% from 2019 to 2027 to reach $2.39 billion by 2027.

The growth in the POC molecular diagnostics market is mainly attributed to the rising prevalence of chronic diseases, development of CLIA-waived POC molecular diagnostic tests, venture capital funding for the development of POC molecular diagnostic products, growing demand for POC molecular diagnostics, and need for rapid decision making in emergency care departments. Moreover, emerging countries provide increasing growth opportunities for players operating in the POC molecular diagnostics market.

Based on the POC molecular diagnostic products, the kits & assays segment accounted for the largest share of the overall POC molecular diagnostics market in 2019. The large share of this segment is mainly attributed to its frequent use in the molecular diagnostic testing. Moreover, growing focus of key market players on receiving CLIA approval for their products is further supporting the fastest growth of the kits & assays segment.

Based on technology, real-time qualitative polymerase chain reaction (RT-qPCR) technology dominated the overall POC molecular diagnostics market in 2019. Large number of commercially available RT-qPCR based POC molecular diagnostic systems or tests compared to other technologies, need for rapid diagnosis of viral & infectious diseases, and use of RT-qPCR in proteomics & genomics contributed to the largest share of the RT-qPCR technology segment in the overall POC molecular diagnostics market.

In the perspective of end users of POC molecular diagnostics, these products are more beneficial at the physician's offices and diagnostic laboratories for early disease diagnosis and making decision about the therapy to treat the particular disease. Therefore, clinics and diagnostic laboratories held the largest share of the overall POC molecular diagnostics market in 2019. Moreover, growing number of physicians adopting POC technologies and increasing focus of key companies on offering disease-specific POC molecular diagnostics drives the growth of the POC molecular diagnostics market for clinics and diagnostic laboratory segment.

An in-depth analysis of the geographic scenario of the overall POC molecular diagnostics market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. North America commanded the largest share of the overall POC molecular diagnostics market in 2019, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The key players operating in the global point of care molecular diagnostics market are Alere Inc. (U.S.), GeneSTAT Molecular Diagnostics, LLC (U.S.), Mesa Biotech Inc. (U.S.), Meridian Bioscience Inc. (U.S.), Danaher Corporation (U.S.), Quidel Corporation (U.S.), Biocartis Group NV (Belgium), bioMerieux SA (France), Thermo Fisher Scientific (U.S.), and F. Hoffmann-La Roche Ltd. (Switzerland), among others.

Scope of the Report:

POC Molecular Diagnostics Market, by Product & Solution

  • Kits & Assays
  • Analyzers
  • Software & Services

POC Molecular Diagnostics Market, by Technology

  • Real-Time Polymerase Chain Reaction (RT-qPCR)
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Other Technologies

POC Molecular Diagnostics Market, by Application

  • Respiratory Diseases
  • Sexually Transmitted Diseases (STDs)
  • Hospital Acquired Infections (HAIs)
  • Oncology
  • Prenatal/Neonatal Testing
  • Other Applications

POC Molecular Diagnostics Market, by End User

  • Clinics and Diagnostic Laboratories
  • Hospital Outpatient Departments and Intensive Care Units (ICUs)
  • Research and Academic Institutes
  • Other End Users

POC Molecular Diagnostics Market, by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
  • Japan
  • China
  • India
  • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East and Africa

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research
  • 2.3. Market Assessment
    • 2.3.1. Market Size Estimation
      • 2.3.1.1. Bottom-Up Approach
      • 2.3.1.2. Top-Down Approach
      • 2.3.1.3. Growth forecast
    • 2.3.2. Market Share Analysis
  • 2.4. Assumptions for the Study
  • 2.5. Limitations for the Study

3 Executive Summary

4. Market insights

  • 4.1. Introduction
  • 4.2. Drivers
    • 4.2.1. Rising Prevalence of Chronic Diseases
    • 4.2.2. Development of CLIA-Waived Molecular POC Tests
    • 4.2.3. Venture Capital Funding for Development of POC Molecular Diagnostics Products
    • 4.2.4. Growing Demand for POC Molecular Diagnostics
    • 4.2.5. Need for Rapid Decision Making in Emergency Care Departments
  • 4.3. Restraints
    • 4.3.1.Technical Requirements & Regulatory Process for High or Moderate Complexity Tests
  • 4.4. Opportunity
    • 4.4.1. Emerging Economies
  • 4.5. Challenge
    • 4.5.1. Low Access for Tests Owing to Reimbursement Cuts

5. POC Molecular Diagnostics Market, by Product

  • 5.1. Introduction
  • 5.2. Kits & Assays
  • 5.3. Analyzers
  • 5.4. Software and Services

6. POC Molecular Diagnostics Market, by Technology

  • 6.1. Introduction
  • 6.2. Real-Time Quantitative Polymerase Chain Reaction (Rt-QPCR)
  • 6.3. Isothermal Nucleic Acid Amplification Technology (INAAT)
  • 6.4. Other Technologies

7. POC Molecular Diagnostics Market, by Application

  • 7.1. Introduction
  • 7.2. Respiratory Diseases
  • 7.3. Sexually Transmitted Diseases (STDs)
  • 7.4. Hospital Acquired infections (HAIs)
  • 7.5. Oncology
  • 7.6. Neonatal & Prenatal Testing
  • 7.7. Other Applications

8. POC Molecular Diagnostics Market, by End User

  • 8.1. Introduction
  • 8.2. Clinics and Diagnostics Laboratories
  • 8.3. Hospital Outpatient Departments & Intensive Care Units (ICUs)
  • 8.4. Research and Academic institute
  • 8.5. Other End Users

9. POC Molecular Diagnostics Market, by Geography

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. U.K.
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Rest of Europe
  • 9.4. Asia Pacific
    • 9.4.1. Japan
    • 9.4.2. China
    • 9.4.3. India
    • 9.4.4. Rest of Asia Pacific (RoAPAC)
  • 9.5. Latin America
  • 9.6. Middle East & Africa

10. Competitive Landscape

  • 10.1. Introduction
  • 10.2. Key Growth Strategies
  • 10.3. Competitive Benchmarking
  • 10.4. Market Share Analysis

11. Company Profiles

  • 11.1. Alere Inc. (Subsidiary of Abbott Laboratories)
  • 11.2. Quidel Corporation
  • 11.3. F. Hoffmann-La Roche Ltd.
  • 11.4. Danaher Corporation
  • 11.5. Thermo Fisher Scientific Inc.
  • 11.6. Biomerieux SA
  • 11.7. Meridian Bioscience, Inc.
  • 11.8. Mesa Biotech Inc.
  • 11.9. GeneSTAT Molecular Diagnostics, LLC
  • 11.10. Biocartis Group NV

12. Appendix

  • 12.1. Questionnaire
  • 12.2. Available Customization

List of Tables

  • Table 1 Global POC Molecular Diagnostics Market: Impact Analysis of Market Drivers (2019-2027)
  • Table 2 Global Number of New Cancer Cases Among 65 Years and Older (In Millions)
  • Table 3 WHO Prevalence of Chlamydia, Gonorrhea, Trichomoniasis, and Syphilis, By Region (In %)
  • Table 4 Some POC Molecular Diagnostic Products with CLIA Waiver
  • Table 5 Global POC Molecular Diagnostics Market: Impact Analysis of Market Restraint (2019-2027)
  • Table 6 Few Examples of Moderate or High Complexity POC Molecular Diagnostics Tests
  • Table 7 Requirements for CLIA Waived, Moderate or High Complexity POC Molecular Diagnostics Tests
  • Table 8 Global POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
  • Table 9 Prices of POC Molecular Diagnostic Kits & Assays
  • Table 10 Key Companies Offering POC Molecular Diagnostic Kits & Assays
  • Table 11 Pipeline POC Molecular Diagnostic Kits & Assays
  • Table 12 Global POC Molecular Diagnostic Kits & Assays Market Size, By Country/Region, 2017-2027 ($Million)
  • Table 13 Key Companies Offering POC Molecular Diagnostic Analyzers
  • Table 14 Global POC Molecular Diagnostic Analyzers Market Size, By Country/Region, 2017-2027 ($Million)
  • Table 15 Key Companies Offering POC Molecular Diagnostic Software & Services
  • Table 16 Global POC Molecular Diagnostic Software and Services Market Size, By Country/Region, 2017-2027 ($Million)
  • Table 17 Comparison Between RT-qPCR and INAAT
  • Table 18 Global POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
  • Table 19 Key Companies Offering RT-qPCR-Based POC Molecular Diagnostics
  • Table 20 Global RT-qPCR-Based POC Molecular Diagnostics Market Size, By Country/Region, 2017-2027 ($Million)
  • Table 21 Key Companies Offering INAAT-Based POC Molecular Diagnostics
  • Table 22 Global INAAT-Based POC Molecular Diagnostics Market Size, By Country/Region, 2017-2027 ($Million)
  • Table 23 Global POC Molecular Diagnostics Market Size for Other Technologies, By Country/Region, 2017-2027 ($Million)
  • Table 24 Global POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
  • Table 25 Commercialized POC Molecular Diagnostics for Respiratory Diseases
  • Table 26 Recent Strategic Developments for Respiratory Disease Diagnosis
  • Table 27 Global POC Molecular Diagnostics Market Size for Respiratory Diseases, By Country/Region, 2017-2027 ($Million)
  • Table 28 Commercialized POC Molecular Diagnostics for STDs
  • Table 29 Pipeline POC Molecular Diagnostics for STDs
  • Table 30 Global POC Molecular Diagnostics Market Size for STDs, By Country/Region, 2017-2027 ($Million)
  • Table 31 Commercialized POC Molecular Diagnostics for Hospital-Acquired Infections (HAIs)
  • Table 32 Global POC Molecular Diagnostics Market Size for HAIs, By Country/Region, 2017-2027 ($Million)
  • Table 33 Commercialized POC Molecular Diagnostics for Oncology
  • Table 34 Global POC Molecular Diagnostics Market Size for Oncology, By Country/Region, 2017-2027 ($Million)
  • Table 35 Commercialized POC Molecular Diagnostics for Neonatal & Prenatal Testing
  • Table 36 Global POC Molecular Diagnostics Market Size for Neonatal & Prenatal Testing, By Country/Region, 2017-2027 ($Million)
  • Table 37 Commercialized POC Molecular Diagnostic for Other Applications
  • Table 38 Global POC Molecular Diagnostics Market Size for Other Applications, By Country/Region, 2017-2027 ($Million)
  • Table 39 Global POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
  • Table 40 Global POC Molecular Diagnostics Market Size for Clinics and Diagnostic Laboratories, By Country/Region, 2017-2027 ($Million)
  • Table 41 Key Companies Offering POC Molecular Diagnostics for Hospital-Acquired Infections (HAIs)
  • Table 42 Global POC Molecular Diagnostics Market Size for Hospital Outpatient Departments and ICUs, By Country/Region, 2017-2027 ($Million)
  • Table 43 Global POC Molecular Diagnostics Market Size for Research and Academic Institutes, By Country/Region, 2017-2027 ($Million)
  • Table 44 Global POC Molecular Diagnostics Market Size for Other End Users, By Country/Region, 2017-2027 ($Million)
  • Table 45 Global POC Molecular Diagnostics Market Size, By Country/Region, 2017-2027 ($Million)
  • Table 46 North America: POC Molecular Diagnostics Market Size, By Country, 2019-2027 ($Million)
  • Table 47 North America: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
  • Table 48 North America: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
  • Table 49 North America: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
  • Table 50 North America: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
  • Table 51 U.S.: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
  • Table 52 U.S.: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
  • Table 53 U.S.: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
  • Table 54 U.S.: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
  • Table 55 Canada: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
  • Table 56 Canada: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
  • Table 57 Canada: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
  • Table 58 Canada: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
  • Table 59 Europe: POC Molecular Diagnostics Market Size, By Country, 2019-2027 ($Million)
  • Table 60 Europe: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
  • Table 61 Europe: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
  • Table 62 Europe: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
  • Table 63 Europe: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
  • Table 64 Germany: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
  • Table 65 Germany: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
  • Table 66 Germany: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
  • Table 67 Germany: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
  • Table 68 France: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
  • Table 69 France: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
  • Table 70 France: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
  • Table 71 France: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
  • Table 72 Italy: Cancer Prevalence Cases, 2010 and 2020
  • Table 73 Italy: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
  • Table 74 Italy: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
  • Table 75 Italy: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
  • Table 76 Italy: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
  • Table 77 U.K.: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
  • Table 78 U.K.: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
  • Table 79 U.K.: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
  • Table 80 U.K.: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
  • Table 81 Spain: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
  • Table 82 Spain: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
  • Table 83 Spain: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
  • Table 84 Spain: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
  • Table 85 Roe: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
  • Table 86 Roe: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
  • Table 87 Roe: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
  • Table 88 Roe: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
  • Table 89 Asia-Pacific: POC Molecular Diagnostics Market Size, By Country, 2019-2027 ($Million)
  • Table 90 Asia-Pacific: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
  • Table 91 Asia-Pacific: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
  • Table 92 Asia Pacific: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
  • Table 93 Asia Pacific: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
  • Table 94 Japan: POC Molecular Diagnostics Market Size, By Product & Solutions, 2017-2027 ($Million)
  • Table 95 Japan: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
  • Table 96 Japan: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
  • Table 97 Japan: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
  • Table 98 China: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
  • Table 99 China: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
  • Table 100 China: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
  • Table 101 China: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
  • Table 102 India: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
  • Table 103 India: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
  • Table 104 India: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
  • Table 105 India: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
  • Table 106 Rest of Asia-Pacific: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
  • Table 107 Rest of Asia-Pacific: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
  • Table 108 Rest of Asia-Pacific: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
  • Table 109 Rest of Asia-Pacific: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
  • Table 110 Latin America: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
  • Table 111 Latin America: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
  • Table 112 Latin America: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
  • Table 113 Latin America: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
  • Table 114 Middle East & Africa: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
  • Table 115 Middle East & Africa: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
  • Table 116 Middle East & Africa: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
  • Table 117 Middle East & Africa: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
  • Table 118 Number of Developments by The Major Players During 2016-2020

List of Figures

  • Figure 1 Research Process
  • Figure 2 Key Secondary Sources
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
  • Figure 6 Market Size Estimation
  • Figure 7 Global POC Molecular Diagnostics Market, By Product & Solution, 2019 Vs. 2027 ($Million)
  • Figure 8 Global POC Molecular Diagnostics Market Size, By Technology, 2019 Vs. 2027 ($Million)
  • Figure 9 Global POC Molecular Diagnostics Market Size, By Application, 2019 Vs. 2027 ($Million)
  • Figure 10 Global POC Molecular Diagnostics Market Size, By End User, 2019 Vs. 2027 ($Million)
  • Figure 11 POC Molecular Diagnostics Market, By Region
  • Figure 12 Market Dynamics
  • Figure 13 Global Geriatric Population, 2005-2020 (In Million)
  • Figure 14 Disposable Personal Income in China (In $)
  • Figure 15 Percent of Major Disease Groups to Total Disability-Adjusted Life Years (DALYS) In India, 1990 and 2016
  • Figure 16 Global POC Molecular Diagnostics Market Size, By Product & Solution, 2019-2027 ($Million)
  • Figure 17 Global POC Molecular Diagnostics Market Size, By Technology, 2019-2027 ($Million)
  • Figure 18 Global POC Molecular Diagnostics Market Size, By Application, 2019-2027 ($Million)
  • Figure 19 Global Prevalence of Gonorrhea in Women and Men, 2012 and 2016 (In %)
  • Figure 20 Global Prevalence of Trichomoniasis in Women and Men, 2012 and 2016 (In %)
  • Figure 21 Global POC Molecular Diagnostics Market Size, By End User, 2019-2027 ($Million)
  • Figure 22 U.S. Distribution of Outpatient Vs. Inpatient Revenues, 2010 - 2016
  • Figure 23 U.S.: Home Healthcare Spending, 2015-2026 ($Billion)
  • Figure 24 Global POC Molecular Diagnostics Market Size, By Region, 2019-2027 ($Million)
  • Figure 25 North America: POC Molecular Diagnostics Market Size, By Country, 2019-2027 ($Million)
  • Figure 26 U.S. Influenza Burden (2010-2018)
  • Figure 27 U.S. Health Expenditure for Home Health Care (2005-2017) (In $Billion)
  • Figure 28 Canada: Chlamydia and Gonorrhea Infections Cases (2006-2017)
  • Figure 29 Europe: POC Molecular Diagnostics Market Size, By Country, 2019-2027 ($Million)
  • Figure 30 Germany: VRE Infection Data for ICUs and Surgical Departments, By Infection Site, 2010-2016 (%)
  • Figure 31 France: Percentage of Older People (65 Years and Above), 2010-2050
  • Figure 32 Asia-Pacific: POC Molecular Diagnostics Market Size, By Country, 2019-2027 ($Million)
  • Figure 33 China Population Growth Chart
  • Figure 34 Key Growth Strategies Adopted by Leading Players -2016-2020
  • Figure 35 POC Molecular Diagnostics: Competitive Benchmarking
  • Figure 36 Global POC Molecular Diagnostics Market Share, By Key Players, 2018 (%)
  • Figure 37 Abbott Laboratories: Financial Overview (2018)
  • Figure 38 Quidel Corporation: Financial Overview (2018)
  • Figure 39 F. Hoffmann-La Roche Ltd.: Financial Overview (2018)
  • Figure 40 Danaher Corporation: Financial Overview (2019)
  • Figure 41 Thermo Fisher Scientific Inc.: Financial Overview (2018)
  • Figure 42 Biomerieux SA: Financial Overview (2018)
  • Figure 43 Meridian Bioscience, Inc.: Financial Overview (2019)
  • Figure 44 Biocartis Group NV: Financial Overview (2018)